{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:22Z","timestamp":1786118662212,"version":"build-2736575974"},"reference-count":114,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Techinvention Lifecare Pvt Ltd"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2483043","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T05:02:56Z","timestamp":1743051776000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Overcoming barriers to medical countermeasures: Strengthening global biosecurity"],"prefix":"10.1080","volume":"21","author":[{"given":"Kaushal","family":"Sharma","sequence":"first","affiliation":[{"name":"TechInvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Syeda","sequence":"additional","affiliation":[{"name":"TechInvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket M.","family":"Shah","sequence":"additional","affiliation":[{"name":"Techinvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali A.","family":"Kori","sequence":"additional","affiliation":[{"name":"Techinvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratiksha","family":"Shetty","sequence":"additional","affiliation":[{"name":"Techinvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniya","family":"Kazi","sequence":"additional","affiliation":[{"name":"Techinvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Khaiterpal","sequence":"additional","affiliation":[{"name":"Techinvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasiya","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Techinvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarang","family":"Pathak","sequence":"additional","affiliation":[{"name":"Techinvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Techinvention Lifecare Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304686"},{"key":"e_1_3_4_3_1","unstructured":"Commissioner O of the. What are medical countermeasures? FDA; 2024 published online Oct 1 [accessed Jan 22 2025]. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/about-mcms\/what-are-medical-countermeasures."},{"key":"e_1_3_4_4_1","unstructured":"CDC. Office of readiness and response. Off. Readiness response. 2025 published online Jan 7 [accessed Jan 22 2025]. https:\/\/www.cdc.gov\/orr\/index.html."},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15338"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00672-y"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/life13071530"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2129930"},{"key":"e_1_3_4_9_1","first-page":"e52","article-title":"Non-pharmacologic interventions in COVID-19 pandemic management; a systematic review","volume":"11","author":"Etemad K","year":"2023","unstructured":"Etemad K, Mohseni P, Shojaei S, Mousavi SA, Taherkhani S, Atatalab FF, Ghajari H, Nazari SS, Karami M, Izadi N, et al. Non-pharmacologic interventions in COVID-19 pandemic management; a systematic review. Arch Acad Emerg Med. 2023;11:e52.","journal-title":"Arch Acad Emerg Med"},{"key":"e_1_3_4_10_1","unstructured":"GHTC Medical Countermeasures Platform Priorities. Global health technologies coalition. 2025 [accessed Jan 22 2025]. https:\/\/www.ghtcoalition.org\/documents\/pdf\/GHTC%20MCMs%20platform%20priorities.pdf."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012436"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-024-01066-4"},{"key":"e_1_3_4_13_1","unstructured":"Russia\u2019s COVID-19 vaccination begins in Moscow. 2020 published online Dec 5 [accessed Jan 22 2025]. https:\/\/www.dw.com\/en\/coronavirus-russia-rolls-out-covid-vaccination-in-moscow\/a-55831123."},{"key":"e_1_3_4_14_1","unstructured":"UK marks one year since deploying world\u2019s first COVID-19 vaccine. Gov. UK. 2021 published online Dec 8 [accessed Jan 24 2025]. https:\/\/www.gov.uk\/government\/news\/uk-marks-one-year-since-deploying-worlds-first-covid-19-vaccine."},{"key":"e_1_3_4_15_1","unstructured":"FDA approves first COVID-19 vaccine. FDA. 2021 published online Aug 23 [accessed Jan 24 2025]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-covid-19-vaccine."},{"key":"e_1_3_4_16_1","unstructured":"COVID-19 vaccination: vaccination coverage. Govt can. 2024 published online July 12 [accessed Jan 24 2025]. https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/."},{"key":"e_1_3_4_17_1","unstructured":"India rolls out the world\u2019s largest COVID-19 vaccination drive. 2021 published onlineJan 16 [accessed Jan 24 2025]. https:\/\/www.who.int\/india\/news\/feature-stories\/detail\/india-rolls-out-the-world-s-largest-covid-19-vaccination-drive#:~:text=India%20rolled%20out%20the%20world\u2019s its%20states%20and%20union%20territories."},{"key":"e_1_3_4_18_1","unstructured":"Nigeria: COVID-19 vaccine rollout kicks off in Africa\u2019s most populous country. 2021 published online April 6 [accessed Jan 24 2025]. https:\/\/www.un.org\/africarenewal\/magazine\/april-2021\/nigeria-covid-19-vaccine-rollout-kicks-africas-most-populous-country."},{"key":"e_1_3_4_19_1","unstructured":"Ethiopia introduces COVID-19 vaccine in a national launching ceremony. 2021 published online March 13 [accessed Jan 24 2025]. https:\/\/www.afro.who.int\/news\/ethiopia-introduces-covid-19-vaccine-national-launching-ceremony."},{"key":"e_1_3_4_20_1","unstructured":"Brazil will receive the first vaccines against COVID-19 through the COVAX mechanism this Sunday. 2021 published online March 21 [accessed Jan 24 2025]. https:\/\/www.unicef.org\/lac\/en\/press-releases\/brazil-will-receive-first-vaccines-against-covid-19-through-covax-mechanism-sunday#:~:text=Brasilia%2C%20Brazil%2C%20March%2021%2C Nations%20Children\u2019s%20Fund%20(UNICEF)%2C."},{"key":"e_1_3_4_21_1","unstructured":"WHO Medical Countermeasures Platform Design & Consultation Process \u2013 Q&A. World Health Organization. 2025 [accessed Jan 22 2025]. https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/emergencies\/countermeasures-platform-design-and-consultation-process-qa.pdf?sfvrsn=2d98b641_7."},{"key":"e_1_3_4_22_1","unstructured":"Developing a new platform for equitable access to medical countermeasures in pandemics. World Health Organization; 2023."},{"key":"e_1_3_4_23_1","unstructured":"World Bank Group. World bank board approves new fund for pandemic prevention preparedness and response (PPR). World bank. 2022 published online June 30. https:\/\/www.worldbank.org\/en\/news\/press-release\/2022\/06\/30\/-world-bank-board-approves-new-fund-for-pandemic-prevention-preparedness-and-response-ppr."},{"key":"e_1_3_4_24_1","unstructured":"Glassman A Silverman R Other Contributors. Rapid and equitable access to medical countermeasures: lessons landscape and near-term recommendations. Center for Global Development (CGD); 2022."},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16349"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049505"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-022-01678-5"},{"key":"e_1_3_4_28_1","unstructured":"Expanding the capacity to produce vaccines in Africa: enablers and barriers. United States pharmacopeia (USP). 2023 [accessed Jan 22 2025]. https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/our-work\/global-public-health\/vaccine-manufacturing-in-africa_white-paper_feb-2023.pdf."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100158"},{"key":"e_1_3_4_30_1","unstructured":"UNICEF South Asia. UNICEF-WHO: COVAX ultra-low temperature freezers boost vaccine storage capacity to nine million. 2021; published online Sept 28 [accessed Jan 22 2025]. https:\/\/www.unicef.org\/rosa\/press-releases\/unicef-who-covax-ultra-low-temperature-freezers-boost-vaccine-storage-capacity-nine."},{"key":"e_1_3_4_31_1","unstructured":"Reshetnik V. UNICEF delivered ultra-cold freezers for COVID-19 vaccines to Ukraine under COVAX. 2021 published online Sept 23 [accessed Jan 22 2025]. https:\/\/www.unicef.org\/ukraine\/en\/press-releases\/unicef-delivered-ultra-cold-freezers-covid-19-vaccines-ukraine-under-covax."},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020430"},{"key":"e_1_3_4_33_1","unstructured":"Improving the development and deployment of rapid diagnostic tests in LMICs. London United Kingdom: The Academy of Medical Sciences; 2016."},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2022-219333"},{"key":"e_1_3_4_35_1","unstructured":"Market failures and opportunities for increasing access to diagnostics in low- and middle income countries. Program for appropriate technology in health (PATH)."},{"key":"e_1_3_4_36_1","unstructured":"The lancet commission on diagnostics: transforming access to diagnostics - PubMed. [accessed Jan 22 2025]. https:\/\/pubmed.ncbi.nlm.nih.gov\/34626542\/."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2021.100093"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00460-0"},{"key":"e_1_3_4_39_1","unstructured":"Expanding access to monoclonal antibody-based products: a global call to action. Wellcome Trust & IAVI [accessed Jan 22 2025]. https:\/\/wellcome.org\/sites\/default\/files\/expanding-access-to-monoclonal-antibody-based-products.pdf."},{"key":"e_1_3_4_40_1","unstructured":"WHO. Call for consultant on monoclonal antibodies for infectious diseases. 2021 published online July 23 [accessed Jan 22 2025]. https:\/\/www.who.int\/news-room\/articles-detail\/call-for-consultant-on-monoclonal-antibodies-for-infectious-diseases."},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-023-00473-z"},{"key":"e_1_3_4_42_1","unstructured":"IAVI and Impact Global Health. Access to monoclonal antibodies in Africa: a call to action. 2024."},{"key":"e_1_3_4_43_1","unstructured":"Biotherapeutics. [accessed Jan 22 2025]. https:\/\/medicinespatentpool.org\/what-we-do\/biotherapeutics."},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/poms.13828"},{"key":"e_1_3_4_45_1","unstructured":"Chaib F. Shortage of personal protective equipment endangering health workers worldwide. In: WHO calls on industry and governments to increase manufacturing by 40 per cent to meet rising global demand. 2020 [accessed Jan 22 2025]. https:\/\/www.who.int\/news\/item\/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide."},{"key":"e_1_3_4_46_1","unstructured":"Kinder M. Essential but undervalued: millions of health care workers aren\u2019t getting the pay or respect they deserve in the COVID-19 pandemic. 2020. https:\/\/www.brookings.edu\/articles\/essential-but-undervalued-millions-of-health-care-workers-arent-getting-the-pay-or-respect-they-deserve-in-the-covid-19-pandemic\/."},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046199"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.928065"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31093-X"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30068-9"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30517-X"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.12.03072"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1087662"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.06.007"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00334-2"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4750"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2021.1906926"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-00470-9"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-021-00659-7"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1249"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005347"},{"key":"e_1_3_4_62_1","doi-asserted-by":"crossref","first-page":"e070650","DOI":"10.1136\/bmj-2022-070650","article-title":"It is not too late to achieve global covid-19 vaccine equity","volume":"376","author":"Yamey G","year":"2022","unstructured":"Yamey G, Garcia P, Hassan F, Mao W, McDade KK, Pai M, Saha S, Schellekens P, Taylor A, Udayakumar K. It is not too late to achieve global covid-19 vaccine equity. BMJ. 2022;376:e070650.","journal-title":"BMJ"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00242-7"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.709127"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32642-8"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001289"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9329"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250495"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-023-00987-w"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01454-y"},{"key":"e_1_3_4_71_1","first-page":"1","article-title":"Drug development in low- and middle-income countries: opportunity or exploitation?","volume":"42","author":"Jalali R","year":"2022","unstructured":"Jalali R, Nogueira-Rodrigues A, Das A, Sirohi B, Panda PK. Drug development in low- and middle-income countries: opportunity or exploitation? Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet. 2022;42:1\u20138.","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-00970-z"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-018-0748-6"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30542-8"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1038840"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-006169"},{"key":"e_1_3_4_77_1","unstructured":"M\u00e9decins Sans Fronti\u00e8res (MSF) Access Campaign. Removing intellectual-property barriers from COVID-19 vaccines and treatments for people in South Africa. 2022."},{"key":"e_1_3_4_78_1","first-page":"159","article-title":"Improving access to COVID-19 vaccines: an analysis of TRIPS waiver discourse among WTO members, civil society organizations, and pharmaceutical industry stakeholders","volume":"24","author":"Kohler J","year":"2022","unstructured":"Kohler J, Wong A, Tailor L. Improving access to COVID-19 vaccines: an analysis of TRIPS waiver discourse among WTO members, civil society organizations, and pharmaceutical industry stakeholders. Health Hum Rights. 2022;24:159\u2013175.","journal-title":"Health Hum Rights"},{"key":"e_1_3_4_79_1","unstructured":"America O. Intellectual property and access to medicine. Oxfam Am [accessed Jan 23 2025]. https:\/\/www.oxfamamerica.org\/explore\/issues\/economic-well-being\/intellectual-property-and-access-to-medicine\/."},{"key":"e_1_3_4_80_1","article-title":"Strengthening regulatory systems to improve medical product quality in low- and MiddleIncome countries. Promoting the Quality of Medicines (PQM) Program","author":"Kaddu G","year":"2018","unstructured":"Kaddu G, D\u2019Amore E, Clark A, Nkansah, P. Strengthening regulatory systems to improve medical product quality in low- and MiddleIncome countries. Promoting the Quality of Medicines (PQM) Program. United States Pharmacopeial Convention. 2018 [accessed March 22, 2025]. https:\/\/www.usppqm.org\/sites\/default\/files\/pqms\/article\/strengtheningregulatorysystemsforqa_sept2018.pdf.","journal-title":"United States Pharmacopeial Convention"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012883"},{"key":"e_1_3_4_82_1","unstructured":"Sillo H. WHO listed authorities framework. Team lead regulatory systems strengthening regulation and safety unit. WHO; 2020."},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00898-z"},{"key":"e_1_3_4_84_1","unstructured":"WHO. Local production & assistance (LPA) unit: WHO. [accessed Jan 22 2025]. https:\/\/www.who.int\/teams\/regulation-prequalification\/lpa."},{"key":"e_1_3_4_85_1","unstructured":"Regulation and prequalification: LPA unit (WHO). https:\/\/www.who.int\/teams\/regulation-prequalification\/lpa\/capacity-building-and-technical-assistance."},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01119-4"},{"key":"e_1_3_4_87_1","unstructured":"BioNTech. BioNTech starts construction of first mRNA vaccine manufacturing facility in Africa. Globe newswire. 2022 published online June 23 [accessed Jan 23 2025]. https:\/\/investors.biontech.de\/news-releases\/news-release-details\/biontech-starts-construction-first-mrna-vaccine-manufacturing."},{"key":"e_1_3_4_88_1","unstructured":"Moderna announces memorandum of understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa. 2022 published online March 7 [accessed Jan 23 2025]. https:\/\/investors.modernatx.com\/news\/news-details\/2022\/Moderna-Announces-Memorandum-of-Understanding-with-the-Government-of-the-Republic-of-Kenya-to-Establish-its-First-mRNA-Manufacturing-Facility-in-Africa\/default.aspx."},{"key":"e_1_3_4_89_1","unstructured":"WHO. Establishing manufacturing capabilities for human vaccines: white paper. 2017."},{"key":"e_1_3_4_90_1","unstructured":"Bharat Biotech. COVAXIN\u00ae - India\u2019s first indigenous COVID-19 vaccine. [accessed Jan 23 2025]. https:\/\/www.bharatbiotech.com\/covaxin.html#:~:text=COVAXIN%C2%AE%20%2D%20India\u2019s%20First Institute%20of%20Virology%20(NIV)."},{"key":"e_1_3_4_91_1","unstructured":"Al Idrus A. Pfizer teams up with the Biovac institute to produce prevenar 13 in South Africa. fiercepharma. https:\/\/www.fiercepharma.com\/r-d\/pfizer-teams-up-biovac-institute-to-produce-prevenar-13-south-africa."},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2020529"},{"key":"e_1_3_4_93_1","unstructured":"IFPMA BIO DCVMN EFPIA JPMA PhRMA. Delivering equitable access in pandemics: biopharmaceutical industry commitments. 2024 published online March 11 [accessed Feb 28 2025]. https:\/\/www.ifpma.org\/news\/delivering-equitable-access-in-pandemics-biopharmaceutical-industry-commitments\/."},{"key":"e_1_3_4_94_1","unstructured":"Kazaz B Webster S Yadav P. Incentivizing COVID-19 vaccine developers to expand manufacturing capacity. 2021 published online March 26. https:\/\/www.cgdev.org\/publication\/incentivizing-covid-19-vaccine-developers-expand-manufacturing-capacity."},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-011172"},{"key":"e_1_3_4_96_1","unstructured":"Initiatives for African vaccine manufacturing approved by Gavi board. Gavi the Vaccine Alliance; https:\/\/www.gavi.org\/news\/media-room\/initiatives-african-vaccine-manufacturing-approved-gavi-board."},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216287"},{"key":"e_1_3_4_98_1","unstructured":"Recommendations to improve local production of diagnostics in low- and middle-income countries. 2021 published online July 8 [accessed Jan 23 2025]. https:\/\/www.msfaccess.org\/improve-local-production-diagnostics."},{"key":"e_1_3_4_99_1","unstructured":"Intellectual Property Rights Regimes Their Assets and Limitations. Global Solutions Initiative Think7 Japan (T7JP). [accessed Jan 23 2025]. https:\/\/www.global-solutions-initiative.org\/wp-content\/uploads\/think7-uploads\/2023\/04\/T7JP_TF3_Intellectual-Property-Rights-Regimes-Their-Assets-and-Limitations.pdf."},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.techsoc.2023.102233"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.31486\/toj.19.0068"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.27252"},{"key":"e_1_3_4_103_1","unstructured":"United Nations. European and developing countries clinical trials partnership (EDCTP). [accessed Jan 23 2025]. https:\/\/sdgs.un.org\/partnerships\/european-and-developing-countries-clinical-trials-partnership-edctp."},{"key":"e_1_3_4_104_1","unstructured":"Key features of EDCTP. EDCTP. [accessed Jan 23 2025]. https:\/\/www.edctp.org\/about-us\/key-features-of-edctp\/."},{"key":"e_1_3_4_105_1","unstructured":"Oxford University Clinical Research Unit (OUCRU). OUCRU Oxford University Clinical Research Unit [accessed Jan 23 2025]. https:\/\/chatgpt.com\/c\/678f3b02-c264-800d-86d1-a360ff8b15be."},{"key":"e_1_3_4_106_1","unstructured":"The Platform for ACT-A Civil Society & Community Representatives. 2022 published online May 17 [accessed Jan 23 2025]. https:\/\/thedocs.worldbank.org\/en\/doc\/8c4623354e95846d8a77fd2f1c2ad5ea-0290032022\/original\/Platform-for-ACT-A-Civil-Society-and-Communities-Representatives.pdf."},{"key":"e_1_3_4_107_1","unstructured":"Save the Children UK. Functioning regulatory systems: the cure for lack of access to medicines in low- and middle-income countries. 2019. https:\/\/www.savethechildren.org.uk\/blogs\/2019\/functioning-regulatory-systems-the-cure-for-lack-of-access-to-medicines-in-low-and-middle-income-countries."},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166515"},{"key":"e_1_3_4_109_1","first-page":"1933","article-title":"Effective contact tracing system minimizes COVID-19 related infections and deaths: policy lessons to reduce the impact of future pandemic diseases","volume":"12","author":"Benati I","year":"2022","unstructured":"Benati I, Coccia M. Effective contact tracing system minimizes COVID-19 related infections and deaths: policy lessons to reduce the impact of future pandemic diseases. J Public Adm Gov. 2022 Dec;12:1933\u20131933.","journal-title":"J Public Adm Gov"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2024.102538"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111678"},{"key":"e_1_3_4_112_1","first-page":"381","article-title":"Technological exaptation and crisis management: evidence from COVID\u201019 outbreaks","volume":"51","author":"Ardito L","year":"2021","unstructured":"Ardito L, Coccia M, Messeni Petruzzelli A. Technological exaptation and crisis management: evidence from COVID\u201019 outbreaks. RD Manag. 2021;51:381\u2013392.","journal-title":"RD Manag"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.112314"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81442-x"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.138474"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2483043","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2483043","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2483043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:38:52Z","timestamp":1786034332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2483043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2483043"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2483043","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2483043"}}